BAFF-R (CT) Blocking Peptide

BAFF-R (CT) Blocking Peptide

Product No.: B504

[product_table name="All Top" skus="B504"]

- -
- -
Target
B-Cell Activating Factor Receptor
Product Type
Blocking Peptide
Alternate Names
BAFF Receptor BR3, TNFRSF13, BlyS Receptor 3

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 169 to 183 of Human BAFF-R protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
15 amino acids near the carboxy terminus of human BAFF Receptor.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
BAFF receptor (BAFFR) is a type III transmembrane protein and member of the TNF receptor (TNFR) super family. It is highly expressed in spleen, lymph node, B-cells and peripheral blood leukocytes. BAFFR plays a role in nearly all stages of differentiation of B-cells from development to the maintenance of long-lived bone marrow plasma cells. BAFFR signals by activation of the NF-kappaB signaling pathway. Overexpression of the BAFFR ligand, BAFF, in mice leads to autoimmune characteristics similar to systemic lupus erythematosus (SLE) and Sjogren’s syndrome. Furthermore, high levels of BAFF have been detected in the serum of humans with SLE, rheumatoid arthritis, Sjogren’s syndrome and systemic sclerosis. Inhibition of BAFFR signaling with BAFFR-Ig has been successful in treating SLE and rheumatoid arthritis in mouse models. In addition misexpression of BAFFR brought about by retroviral integration has lead to leukemia in some strains of mice. This makes BAFFR an obvious candidate for further therapeutic investigation. Recombinant human BAFFR has a molecular weight of 7.7 kDa and contains 76 amino acid residues corresponding to the extracellular portion of the full native BAFFR.

Antigen Details

References & Citations

1. Tschopp J, Martinon F, and Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 2003; 4:95-104. 2. Bruey JM, Bruey-Sedano N, Newman R, et al. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages. J. Biol. Chem. 2004; 279:51897-907. 3. Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20:319-25. 4. Martinon F and Tschopp J. NLRs join TLRs as innate sensors of pathogens. TRENDS Imm. 2005; 26:447-54.
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.